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Abstract
Background: Central line-associated bloodstream infections (CLABSI) represent a serious patient safety issue. To prevent
these infections, bundled interventions are increasingly recommended. We examine the extent of adoption of Central Line
(CL) Bundle elements throughout US intensive care units (ICU) and determine their effectiveness in preventing CLABSIs.
Methodology/Principal Findings: In this cross-sectional study, National Healthcare Safety Network (NHSN) hospitals
provided the following: ICU-specific NHSN-reported rates of CLABSI/1,000 central line days; policies and compliance rates
regarding bundle components; and other setting characteristics. In 250 hospitals the mean CLABSI rate was 2.1 per 1000
central line days and 49% reported having a written CL Bundle policy. However, of those that monitored compliance, only
38% reported very high compliance with the CL Bundle. Only when an ICU had a policy, monitored compliance, and had
$95% compliance did CLABSI rates decrease. Complying with any one of three CL Bundle elements resulted in decreased
CLABSI rates (b=-1.029, p=0.015). If an ICU without good bundle compliance achieved high compliance with any one
bundle element, we estimated that its CLABSI rate would decrease by 38%.
Conclusions/Significance: In NHSN hospitals across the US, the CL Bundle is associated with lower infection rates only when
compliance is high. Hospitals must target improving bundle implementation and compliance as opposed to simply
instituting policies.
Citation: Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, et al. (2011) Central Line Bundle Implementation in US Intensive Care Units and Impact
on Bloodstream Infections. PLoS ONE 6(1): e15452. doi:10.1371/journal.pone.0015452
Editor: Frank R. DeLeo, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America
Received July 26, 2010; Accepted September 24, 2010; Published January 18, 2011
Copyright:  2011 Furuya et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by National Institutes of Health (R01NR010107). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ps2024@columbia.edu
Introduction
Healthcare-associated infections (HAIs) are a major source of
morbidity and mortality despite often being preventable. Most
HAIs are associated with an invasive device and occur in intensive
care units (ICUs). Of an estimated 99,000 HAI-related deaths per
year, bloodstream infections lead to an estimated 31,000 deaths
per year, with a mean attributable cost of $18,000 per central line-
associated bloodstream infection (CLABSI).[1,2]
In partnership with other national and scientific organizations,
the Institute for Healthcare Improvement (IHI) promoted ‘‘care
bundles’’ as part of its effort to improve patient safety.[3] The IHI
Central Line (CL) Bundle consists of five interventions: hand
hygiene; maximal barrier precautions; chlorhexidine skin antisep-
sis; optimal catheter site selection, with avoidance of the femoral
vein for central venous access in adult patients; and daily review of
the line necessity, with prompt removal of unnecessary lines.[4]
This bundle is being widely promoted for implementation
across the country. For example, 28 state hospital associations
have joined collaboratives to reduce CLABSI in part by using the
CL Bundle.[5] Additionally, as part of the National Patient Safety
Goals (NPSG), beginning in 2010, The Joint Commission is
requiring inclusion of the use of a checklist based on the CL
Bundle (NPSG.07.04.01 items 11-12, 14-17, 17).
Despite the promotion of bundles, questions remain about their
adoption and effectiveness. Bundled policies do not guarantee
reliable execution at the bedside; moreover, even though decreases
in CLABSIs have been reported,[6] these infections continue to be
significant problems in many ICUs.[7] Quasi-experimental studies
point to subsequent decreases in CLABSI rates following bundle
implementation.[8,9] In these publications, a key focus has been
improving the culture of safety, and some have hypothesized that
an overall heightened attention to one clinical issue leads to a
positive ‘‘chain reaction’’ effect that prevents other complica-
tions.[10] If this were the case, implementing one bundle would be
expected to lead to a decrease in other non-targeted HAI rates in
the same setting. In this study, we examine the extent of adoption
of Central Line (CL) Bundle elements throughout US intensive
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CLABSIs.
Methods
Objectives
The objectives of this study were to: 1) examine the extent of
adoption of the CL Bundle in ICUs across the US; 2) determine
the effectiveness of individual bundle elements on reducing
infections; and 3) determine the effectiveness of combinations of
the bundle elements on reducing infections; and 4) determine if the
effect of the bundle elements was specific, or if compliance reduced
infection rates in non-targeted HAIs such as ventilator-associated
pneumonia (VAP).
Participants
To participate, a hospital must have conducted National
Healthcare Safety Network hospitals (NHSN) CLABSI surveil-
lance in an adult medical, medical/surgical, or surgical ICU in
2007 according to CDC protocol;[11] and the ICU must have had
a minimum of 500 device days. There were 441 hospitals eligible
to participate. Our NHSN expert (TH) developed a list of eligible
hospitals and invited them to participate.
Survey
The survey, described in detail elsewhere, was conducted as part
of a larger study assessing infection control resources and practices
and was thus designed to be answered by the director or manager
of each hospital’s infection control department.[12] Respondents
were asked about ICU-specific policies and practices related to the
CL in eligible ICUs. Because we hypothesized that having policies
alone was insufficient to decrease infection rates, for each bundle
component, respondents were asked: a) whether the ICU had a
written CL Bundle policy in place; b) whether compliance was
monitored; and c) if so, how often compliance was observed (all of
the time/95% - 100%; usually/75% - 94%, sometimes/25% -
74%, rarely or never/,25%; and don’t know). Because
compliance with hand hygiene affects all HAIs, compliance with
this crucial policy was not considered specific to the bundle; rather,
it was measured in another section of the survey as a setting-
specific characteristic.
Respondents were also asked about the number of years of
NHSN/NNIS (i.e., National Nosocomial Infection Surveillance
system, the precursor to NHSN) membership. State mandatory
HAI reporting requirements were identified. Other setting
characteristics included hospital teaching status, size and ICU
type.
Ethics
All procedures were reviewed and approved by institutional
review boards (IRB) at Columbia University, CDC, and RAND
Corporation. The requirement to obtain written documentation of
informed consent was waived by the IRBs in accordance with 45
C.F.R. 1 46.117(c). An online information sheet explaining the
study was provided to each of the participants.
Outcome Measurement
Hospitals reported ICU-specific quarterly CLABSI rates as
reported to the NHSN. In collecting these data, all facilities follow
a specific surveillance protocol that defines CLABSIs using
standard CDC definitions.[11] This protocol developed by CDC
epidemiologists include accurate case finding and has both
laboratory and clinical criteria,[13,14] and the protocol has
become the recognized standard for CLABSI identification
globally.[15,16] The sensitivity and specificity of this protocol
has been reported to be 85% and 98.3% respectively.[17]
Statistical Analysis
Descriptive statistics were computed. To understand the
generalizability of our sample, we compared the hospital
demographics and CLABSI rates to published data on all NHSN
hospitals for the same year.
Individual bundle components were characterized based on
compliance during the last time it was monitored. If the rate of
compliance was missing (versus respondent indicating ‘‘don’t
know’’), we assumed compliance to be low and set the value as
rarely/never.
We evaluated the CL Bundle in two ways: by including and
excluding the chlorhexidine skin antisepsis element. We did this
because, while the use of chlorhexidine is easily implemented and
there has been strong evidence for its effectiveness at reducing
CLABSI in many instances,[18] there has also been evidence of its
decreased activity against certain pathogens (gram-negative and
fungal microorganisms)[19] as well as an association between
resistance to methicillin and chlorhexidine.[20-22]
To meet our aims, we first explored if simply having a policy in
place, monitoring compliance with the policy, and/or the level of
compliance was associated with a reduction in CLABSI. Once that
needed level of compliance was established, we then conducted a
set of separate multivariate analyses. In the first analysis, we
examined the impact of the individual bundle elements (Model 1).
Model 2 tested the effect of compliance with at least one element
versus compliance with no elements. Model 3 tested the effect of
compliance with all bundle elements versus compliance with no or
some elements. Last, to help with the translation of these findings,
we calculated the expected percent reduction of CLABSI if an
ICU was able to increase compliance from just one bundle
elements to two elements.
Finally, we wished to assess the validity of our data in order to
exclude any bias due to self-reporting. That is, we wanted to
further exclude the possibility that certain hospitals may have
over-reported CL Bundle compliance and underreported CLABSI
rates in order to make themselves look better than they really were.
To exclude this possibility, in each model we examined the CL
Bundle’s ‘‘cross-over’’ effects by assessing whether compliance
with the CL Bundle was associated with lower rates of ventilator-
associated pneumonia (VAP). As part of the survey we thus asked
hospitals to report their ICU-specific quarterly VAP rates as
reported to NHSN.
All models were multivariate ordinary least squares regressions
with Huber-White standard errors to account for intra-hospital
correlation across ICUs.[23] We controlled for setting character-
istics including ICU type, hand hygiene compliance, and other
hospital characteristics such as region, bed size and teaching status
as described above. Lastly, based on the multivariate results we
predicted how infection rates would change if an ICU moved from
no bundle implementation to full compliance.
Results
Descriptives
A total of 250 hospitals participated (response rate 57%). Table 1
describes the hospitals and ICUs in the study sample. Hospitals in
our sample tended to be on the larger end of the NHSN spectrum;
only 68.4% of our hospitals had 500 beds or less as compared to
84.2% of NHSN hospitals.[24] This is consistent with our
eligibility criteria, which required that hospitals have at least 500
device days in order to participate in the survey. The northeast
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44%). Just over 75% of the hospitals (189) were from states with
mandatory HAI reporting requirements. Most hospitals (54%) had
participated in the NHSN/NNIS for more than three years.
CL Bundle data were available from 415 ICUs, as some
hospitals provided data on more than one ICU. Only 312 of the
ICUs reported CLABSI rates and the mean rate was 2.1/1,000
line days (standard deviation [sd]=2.8, range 0 to 22). Table 2
provides a breakdown of the CLABSI rates by ICU type in our
sample and in all NHSN hospitals. The study sample’s infection
rates were similar to all NHSN hospitals, suggesting that
participants were not dissimilar from the average NHSN hospital.
Table 3 provides a breakdown of CL Bundle elements,
including whether the policy was in place, whether it was
monitored, and the extent each element was executed correctly
based on the last time monitored. While 49% of ICUs had a
written policy regarding the CL Bundle, only 38% of ICUs that
monitored the policy (n=35) reported having implemented the
CL Bundle 95% of the time or greater. Overall, maximal barrier
precautions was the most commonly implemented element, while
daily line checks and optimal site selection were least commonly
implemented.
Multivariate Analyses
Hospital and Infection Prevention and Control
Department Characteristics. Table 4 provides the results of
the multivariate analyses. No setting characteristic, including
hospital size, geographic location and teaching status, had a
significant impact on HAI rates. Hand hygiene compliance was
not independently associated with HAI rates.
CL Bundle Policies. In multivariate analyses, we initially
examined if simply having a CL Bundle policy in place led to
lower CLABSI rates, but this was not the case. Similarly,
monitoring compliance with a bundle policy but having less
than ideal compliance (,95%) showed no association with lower
CLABSI rates. Thus, we conducted our multivariate analyses
looking for an association between high ($95%) compliance and
CLABSI rates.
Taking each CL Bundle element individually, there were no
statistically significant associations with CLABSI rates; however,
all elements trended towards lowering CLABSI rates with the
exception of chlorhexidine use (Model 1). When chlorhexidine was
excluded, we found that having at least one of the bundle elements
implemented correctly (Model 2) decreased CLABSI rates very
significantly (b=-1.029, p=0.015). We did not find that
complying with all bundle elements (as opposed to complying
with no or some elements) was not necessary to show a decrease in
infections (Model 3). Our results do imply that if an average ICU
that complied with no components of the CL Bundle infection rate
were to comply with at least one component of the bundle all the
time, they would experience an estimated 38% decrease in its
CLABSI rate (a reduction from an estimated rate of 2.722 to
1.694). Last, there was no convincing evidence of a cross-over
effect; that is, for all models, compliance with the CL Bundle
elements was never associated with a decrease in VAP rates.
Discussion
To our knowledge, this is the first national study that examines
the real-world practices of monitoring and implementing the
Central Line Bundle in US ICUs, as well as measuring its impact
on CLABSI rates in a detailed fashion. We found that there is wide
variability in both CL Bundle compliance and infection rates.
While it appears that instituting bundle policies is becoming
common (a CL Bundle policy was present in almost half of our
ICUs), only a disappointing 38% of those that monitored bundle
implementation reported full compliance.
Table 1. Description of hospitals and ICUs.
Hospital Characteristics (N=250)
Region N%
Northeast 109 44
South 66 26
Midwest 40 16
West 35 14
Mandatory Reporting (State) 189 76
Bed Count
,201 50 20
201 - 500 145 58
501 - 1000 50 20
.1000 5 2
Hand Hygiene Compliance (N=240)
All of the time (95-100%) 17 7
Usually (75-94%) 104 43
Sometimes (25-74%) 79 33
Rarely/never (,25%) 1 0.4
ICU Type (N=415) N%
Medical 103 25
Medical/Surgical 223 54
Surgical 89 21
doi:10.1371/journal.pone.0015452.t001
Table 2. Comparison of CLABSI rates by ICU Type in the study sample to all participating ICUs in the NHSN.
Study Sample NHSN
N Pooled mean (SD) Median N Pooled mean Median
CLABSI
Medical ICU 74 2.6 (3.2) 1.7 144 2.4 1.9
Medical/Surgical Teaching 111 1.7 (1.9) 1.1 104 2 1.5
Medical/Surgical Other 60 1.6 (2.8) 0 343 1.5 0.6
Surgical 67 2.6 (3.4) 2 128 2.3 1.7
CLABSI = Central Line-Associated Bloodstream Infections, ICU = Intensive Care Unit, NHSN = National Healthcare Safety Network.
doi:10.1371/journal.pone.0015452.t002
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relationship between simply having a bundle policy in place and
lower infection rates. Moreover, even monitoring the bundle
elements and having moderate compliance was not enough to
lower CLABSI rates. We found that only when an ICU had a
bundle policy, monitored compliance with it, and had 95% or
greater compliance did CLABSI rates decrease.
Pronovost et al. found that participation in a collaborative study
focused on actively implementing the CL Bundle lowered CLABSI
rates from .62 to .34 per 1000 central line days.[8] Our study
predicted that if an ICU lacking high compliance to any bundle
element achieved high compliance with any one bundle element,
its CLABSI rate would decrease by 38%. Pronovost also recently
reported that when an ICU continues rigorous monitoring of
compliance, low CLABSI rates are sustained.[25] We find that not
only is monitoring needed, continuous high compliance is also
crucial.
We did not find a significant difference between having high
compliance with all of the bundle elements and having high
compliance with at least one element. This result may be due to
lack of statistical power and the few ICUs in our sample that
actually complied with all elements or a lack of an incremental
effect. While the care bundle is intended to represent an ‘‘all or
nothing’’ approach, it is possible that as long as ICUs perform
even one intervention meticulously, an improvement in infection
rates can be achieved. Indeed, we did find that complying with any
one element was effective. To our knowledge, the incremental
effect of the elements in the CL Bundle has not been previously
studied. More studies are needed to fully understand this finding.
The chlorhexidine element was not associated with a decrease
in CLABSI rates when examined individually, and it weakened the
association of the other bundle elements with CLABSI rates.
While chlorhexidine has been shown to be an effective antiseptic
agent in numerous studies, it is possible that it is not always being
Table 3. Extent to which the ICUs have written policies, monitor implementation and proportion of time the bundle element is
correctly implemented.
Presence of Written
Policy
Presence of Monitoring
for Implementation ICUs Reporting Correct Implementation
*At Least Sometimes At Least Usually All of the Time
N % N% N% N % N %
Central Line Bundle 2 0 4 4 9 9 14 5 7 07 76 2 6 8 3 5 3 8
Barrier precautions 392 94 292 74 247 85 242 83 186 64
Chlorhexidine use 394 95 266 68 229 86 223 84 194 73
Optimal site selection 235 57 133 57 116 87 104 78 58 44
Daily infection check 341 82 194 57 152 78 148 76 104 54
ICU = Intensive Care Unit.
*‘‘At Least Sometimes’’ refers to ICUs with compliance ‘‘sometimes’’ to some bundle elements and ‘‘sometimes,’’ ‘‘usually,’’ or ‘‘all the time’’ to other bundle elements.
doi:10.1371/journal.pone.0015452.t003
Table 4. Multivariate regression analysis of association between central line bundle elements and CLABSI rates controlling for
setting characteristics.
CLABSI
Coef SE P-Value 95% CI
Model 1: Individual Impact of Each Element
CLABSI Bundle Elements
Barrier precautions -0.420 0.710 0.550 -1.815 to 0.975
Chlorhexidine use 0.350 0.667 0.600 -0.961 to 1.661
Optimal site selection -0.617 0.543 0.260 -1.684 to 0.450
Daily check -0.706 0.430 0.100 -1.551 to 0.139
Model 2: Impact of Complying With Any One Element
CLABSI 3-Elements*
At least 1 element -1.029 0.421 0.015 -1.856 to -0.201
Model 3: Impact of Complying With All Bundle Elements
CLABSI Bundle
All elements -0.318 0.943 0.736 -2.171 to 1.535
CI= Confidence Interval, CLABSI = Central Line-associated Bloodstream Infections.
*CLABSI 3-Elements excluded chlorhexidine skin antisepsis from the model. Note: In all models the following co-variates were controlled for: geographic region,
teaching status, hand hygiene, years in NHSN, bedsize, and type of ICU.
doi:10.1371/journal.pone.0015452.t004
Central Line Bundles and Infection
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e15452used optimally in the real world setting. For instance, it is
important to allow the agent to dry fully before line insertion, and
perhaps inserters are not allowing this to occur. Simply using
chlorhexidine may not be enough; compliance with good
technique in using it may be required. An alternative explanation
may be that while it is well documented that chlorhexidine is very
effective in killing gram-positive organisms such as staphylococci,
its efficacy against organisms such as gram negative bacilli and
fungi such as Candida species is more limited.[19,26] Furthermore,
it has been well described that there is an increasing trend in HAI,
including CLABSI, caused by these organism types.[6] With the
wide promotion of the CL Bundle across the country, including
the use of chlorhexidine for skin antisepsis, future research is
warranted.
Limitations
There are a number of limitations to this study. Data were
collected through a survey approach with a 57% response rate
which is comparable to recent surveys of hospital personnel with
reported response rates of 38-53%.[27-29] To examine the
possibility of non-response bias we compared the HAI rates in
the respondent hospitals to those found in published estimates of
all NHSN hospitals. The rates were similar. Second, data were
self-reported by hospitals’ infection control departments’ director/
manager. One issue stemming from mandatory public reporting is
the immense pressure for hospitals to underreport these adverse
outcomes. This pressure to ‘‘look good’’ could motivate hospitals
to underreport CLABSI rates (to NHSN and in our survey) and
also to implement and/or over-report compliance with the CL
Bundle, thus making the association between HAI rates and
bundle strategies appear stronger than it really is. However, we
controlled for mandatory reporting and this was not significantly
associated with lower CLABSI rates. Also, in our data we found
some hospitals reporting higher CLABSI rates also reported less
compliance with the bundles.
Moreover, to more fully test our results, we performed a ‘‘cross-
bundle’’ analysis in which we looked for an association between
CL Bundle compliance and an untargeted HAI, namely rates of
ventilator-associated pneumonia. If some hospitals were intent
upon making themselves look better, one would assume that they
would have reported CL Bundle compliance, CLABSI rates, and
VAP rates as all being better than they were. In that case, high
compliance with the CL Bundle would be associated both with
lower VAP rates as well as lower CLABSI rates. However, we
found only an association between the CL Bundle and CLABSI
and no association between the CL Bundle and VAP rates. Thus,
the cross-bundle analyses suggest that there is no significant bias
due to self-reporting.
Finally, there is the possibility of unobserved and unmeasured
factors confounding the HAI rates, such as patients’ risk severity.
We controlled for many known confounders, and these factors
rarely affected HAI rates to any significant degree. Nonetheless,
future research will include visits to these ICUs to directly observe
compliance, review reported data, and assess for the presence of
other confounding variables.
Last, our data were collected from larger NHSN hospitals,
based on our criteria of a minimum number of device days for
study eligibility. At that time, NHSN hospitals themselves were
mainly large urban tertiary hospitals, thus smaller, rural
institutions may have different findings.
Conclusion
In this national study of real-world practices in US ICUs, the
Central Line Bundle is frequently promoted but seldom well
implemented. The new Joint Commission requirement of
universal central line ‘‘checklists’’ incorporating the CL Bundle
is unlikely to decrease CLABSI rates unless there is proper
implementation and very high compliance.
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